Your institution may have access to this item. Find your institution then sign in to continue.
Title
MTRX1011A, a humanized anti-CD4 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: a Phase I randomized, doubleblind, placebo-controlled study incorporating pharmacodynamic biomarker assessments.